USD 23.15
(-1.53%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 7.1 Billion USD | -3.6% |
2022 | 7.37 Billion USD | -10.33% |
2021 | 8.22 Billion USD | -0.76% |
2020 | 8.28 Billion USD | -0.92% |
2019 | 8.36 Billion USD | -3.27% |
2018 | 8.64 Billion USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 5.74 Billion USD | -9.81% |
2024 Q3 | 5.31 Billion USD | -7.37% |
2024 Q1 | 6.36 Billion USD | -10.4% |
2023 Q2 | 7.13 Billion USD | -1.09% |
2023 FY | 7.1 Billion USD | -3.6% |
2023 Q4 | 7.1 Billion USD | 0.68% |
2023 Q3 | 7.05 Billion USD | -1.1% |
2023 Q1 | 7.21 Billion USD | -2.11% |
2022 Q2 | 8.21 Billion USD | -0.72% |
2022 Q1 | 8.27 Billion USD | 0.67% |
2022 FY | 7.37 Billion USD | -10.33% |
2022 Q4 | 7.37 Billion USD | -10.03% |
2022 Q3 | 8.19 Billion USD | -0.28% |
2021 Q1 | 8.35 Billion USD | 0.87% |
2021 Q4 | 8.22 Billion USD | -0.71% |
2021 FY | 8.22 Billion USD | -0.76% |
2021 Q3 | 8.27 Billion USD | -0.72% |
2021 Q2 | 8.33 Billion USD | -0.2% |
2020 Q2 | 8.33 Billion USD | 652.23% |
2020 Q4 | 8.28 Billion USD | -1.39% |
2020 FY | 8.28 Billion USD | -0.92% |
2020 Q3 | 8.4 Billion USD | 0.8% |
2020 Q1 | 1.1 Billion USD | -86.75% |
2019 Q1 | - USD | 0.0% |
2019 FY | 8.36 Billion USD | -3.27% |
2019 Q4 | 8.36 Billion USD | 0.0% |
2018 FY | 8.64 Billion USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
American Well Corporation | 589.7 Million USD | -1104.946% |
Doximity, Inc. | 1.07 Billion USD | -558.31% |
Evolent Health, Inc. | 2.68 Billion USD | -165.105% |
Phreesia, Inc. | 371.08 Million USD | -1814.824% |
Teladoc Health, Inc. | 4.39 Billion USD | -61.772% |
Veeva Systems Inc. | 5.91 Billion USD | -20.212% |